Clinical Trial Update: Study to Determine the Prevalence of Hypercortisolism in Patients With Type 2 Diabetes and Treatment With Korlym® (Mifepristone) (CATALYST) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial completed to determine how common hypercortisolism is among adults with type 2 diabetes and to evaluate treatment with Korlym (mifepristo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercortisolism
• Type 2 Diabetes Mellitus

Drugs mentioned

• Korlym (mifepristone)

Snippet

Sponsor: Corcept Therapeutics | Conditions: Hypercortisolism, Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED